|
Random thoughts RVX-208 and COVID-19
|
9
|
Resverlogix Corp.
|
Apr 12, 2020 06:52PM
|
|
Re: Shawn lu RSU and option cancelled
|
8
|
Resverlogix Corp.
|
Apr 05, 2020 12:08PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 04:15PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 01:09PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 08:01PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 06:34PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 04:38PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 03:42PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 11:45PM
|
|
Re: Finance
|
9
|
Resverlogix Corp.
|
Mar 30, 2020 01:40AM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Mar 29, 2020 01:58PM
|
|
Re: Covid-19 trial in France dated Mar 20th, ... interesting
|
3
|
Resverlogix Corp.
|
Mar 28, 2020 07:44PM
|
|
Re: Investor Relations....
|
12
|
Resverlogix Corp.
|
Mar 27, 2020 07:03PM
|
|
Lilly's News Release March 23
|
4
|
Resverlogix Corp.
|
Mar 27, 2020 02:43PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 01:11PM
|
|
Re: BETonMACE CKD substudy abstract was supposed to be posted in AJKD
|
11
|
Resverlogix Corp.
|
Mar 26, 2020 10:35PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 06:19PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 26, 2020 05:55PM
|
|
Re: This Covid 19 possibility has
|
4
|
Resverlogix Corp.
|
Mar 25, 2020 08:02PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 04:17PM
|
